Last $17.09 USD
Change Today +0.15 / 0.89%
Volume 204.0K
As of 12:48 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pedro Santabárbara M.D., Ph.D.

Former Chief Medical Officer, Infinity Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 4 different industries.

See Board Relationships
61--
As of Fiscal Year 2013

Background*

Dr. Pedro Santabárbara, M.D., Ph.D., has been the Chief Medical Officer of Infinity Pharmaceuticals, Inc., since November 8, 2010. Dr. Santabarbara has been Senior Director of the Clinical Development Department at PharmaMar SA since July 2005. Dr. Santabarbara serves as Vice President of Clinical Research at OSI Pharmaceuticals Inc. He has been Vice President of Strategic Development and Medical Affairs at PharmaMar, SA since April 2007 and served as its Medical Director. ...

Read Full Background

Corporate Headquarters*

780 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-453-1000
Fax: 617-453-1001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1984
Universitat de Barcelona
MD 1974
Universitat de Barcelona

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INFI:US $17.09 USD +0.15

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INFINITY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.